TURIN - Covid-19 and the lockdown did not affect the management of the dermatological patient in the IMI centers (Italian Melanoma Intergroup), present within the hospital oncology centers of excellence.
In some respects the situation has even improved.
Not only that, during the long period of closure, genetic teleconsultations increased by 34%.
This is what emerges from the XXVII National Congress of IMI after tracing the state of the art of new therapies.
In diagnosis and treatment, the multidisciplinary approach that sees dermatologists, oncologists, geneticists, radiologists, surgeons and even artificial intelligence united to agree on the most suitable therapies for each patient wins.
This approach, thanks to adjuvant therapies, has reduced by 80% the interventions on positive sentinel lymph nodes with microscopic metastases, also unnecessary lymph node dissections have decreased, while the interventions on patients once considered inoperable have significantly increased.
(HANDLE).